| -0.58 / -2.51%|
The 7 analysts offering 12-month price forecasts for Isis Pharmaceuticals Inc have a median target of 18.00, with a high estimate of 31.00 and a low estimate of 7.00. The median estimate represents a -20.00% decrease from the last price of 22.50.
The current consensus among 9 polled investment analysts is to Buy stock in Isis Pharmaceuticals Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.